Perrigo Co PLC (PRGO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

515 EASTERN AVENUE ALLEGAN, MI 49010

Perrigo is a global healthcare supplier that develops, manufactures and distributes over-the-counter and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API). Co.'s primary markets and locations of manufacturing and logistics operations are the U.S., Israel, Mexico, U.K. and Australia. Co. has four reportable segments, aligned primarily by type of product: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals and API. In addition, Co. has an Other category that consists of the Israel Pharmaceutical and Diagnostic Products operating segment.

Data as of 2021-02-20 12:45:12 -0500
Market Cap5.746 Billion Shares Outstanding136.491 Million Avg 30-day Volume1.207 Million
P/E Ratio-870.64909 Dividend Yield2.124 EPS-0.048
Price/Sales1.2 Debt to Equity1.99 EBITDA890.125 Million
Price to Book Value1.05 Forward PE Enterprise Value8.85 Billion
Total Cash849.4 Million Current Debt1.336 Billion Gross Profit1.827 Billion
BETA0.88487 52-week High/Low62.8 / 39.49 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PRGO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 6 -33.33% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 331 330 0.3% 87 (5.25%) 80 (4.98%) 8.75%
13F shares: 110.543 Million 113.694 Million -2.77% 17.991 Million 20.422 Million -11.91%
% Ownership 80.9888 83.2975 -2.77% 13.1807 14.9622 -11.91%
New Positions: 50 34 47.06% 23 13 76.92%
Increased Positions 106 119 -10.92% 27 27 0.0%
Closed Positions 43 44 -2.27% 15 12 25.0%
Reduced Positions 128 125 2.4% 34 29 17.24%
Total Calls 731.686 Thousand 1.619 Million -54.82% 143.4 Thousand 187.3 Thousand -23.44%
Total Puts 645.163 Thousand 863.517 Thousand -25.29% 128.1 Thousand 187 Thousand -31.5%
PUT/CALL Ratio 0.88 0.53 66.04% 0.89 1.0 -11.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PRGO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRGO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

7.5 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

4.3 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DILLARD JAMES E III EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
7,517 2021-02-05 3

SOROTA RICHARD S EVP & PRESIDENT CSCA

  • Officer
7,513 2021-01-06 2

ASHFORD ORLANDO D

  • Director
0 2020-12-15 1

SAMUELS THEODORE R. II

  • Director
32,408 2020-11-09 4

CLASSON ROLF A

  • Director
10,870 2020-11-09 3

WILLIS ROBERT EVP & CHRO

  • Officer
2,055 2020-08-14 5

DOYLE KATHERINE C.

  • Director
0 2020-08-12 2

ANDERSEN SVEND EVP & PRESIDENT CHCI

  • Officer
18,230 2020-08-11 3

KINGMA TODD W EXECUTIVE VP, GENERAL COUNSEL

  • Officer
41,395 2020-06-29 3

KOCHAN SHARON EVP, GM INTERNATIONAL

  • Officer
30,420 2020-06-29 3

FARRINGTON THOMAS EVP AND CIO

  • Officer
16,441 2020-06-29 4

NEEDHAM JEFFREY EVP, PRESIDENT CHC AMERICAS

  • Officer
31,191 2020-06-29 3

JANISH RONALD CRAIG EVP, GLOBAL OP. & SUPPLY CHAIN

  • Officer
13,600 2020-06-29 4

QUINN GRAINNE EVP, CHIEF MEDICAL OFFICER

  • Officer
4,659 2020-06-29 3

O'CONNOR DONAL

  • Director
11,635 2020-05-15 2

PARKER GEOFFREY M.

  • Director
14,091 2020-05-15 2

KINDLER JEFFREY B

  • Director
7,957 2020-05-15 2

ALFORD BRADLEY A

  • Director
7,960 2020-05-15 2

KARABOUTIS ADRIANA

  • Director
7,429 2020-05-15 2

MANN ERICA L

  • Director
2,905 2020-05-15 2

SILCOCK RAYMOND EVP, CHIEF FINANCIAL OFFICER

  • Officer
2,603 2020-04-03 2

KESSLER MURRAY S CEO

  • Officer
  • Director
25,341 2020-03-06 3

WINOWIECKI RONALD CFO

  • Officer
6,952 2019-08-22 0

SMITH JEFFREY C

  • Director
10,046,234 2019-05-15 0

WENINGER PAUL EVP, QUALITY OPERATIONS

  • Officer
5,392 2019-02-26 0

WESOLOWSKI JOHN EVP, PRESIDENT RX

  • Officer
2,431 2019-02-26 0

COHEN GARY M

  • Director
20,317 2018-11-14 0

MICHAUD JAMES R EVP, CHIEF HR OFFICER

  • Officer
0 2018-10-08 0

BRLAS LAURIE

  • Director
15,329 2018-06-06 0

ROEHRHOFF UWE CEO

  • Officer
  • Director
7,500 2018-03-08 0

HENDRICKSON JOHN T CEO

  • Officer
18,321 2017-11-03 0

JANDERNOA MICHAEL J

  • Director
No longer subject to file 2016-12-31 0

BROWN JUDY L EVP, BUSINESS OPS & CFO

  • Officer
10,007 2016-11-25 0

KUNKLE GARY K JR

  • Director
25,687 2016-09-09 0

MORRIS HERMAN JR

  • Director
10,202 2016-09-08 0

HOFFING ELLEN RANDI

  • Director
9,084 2016-05-19 0

YANAI SHLOMO

  • Director
443 2016-05-19 0

FOUSE JACQUALYN A

  • Director
3,916 2016-05-04 0

PAPA JOSEPH C CEO

  • Officer
  • Director
  • CHAIRMAN
118,515 2016-02-26 0

BOOTHE DOUGLAS EVP & GM PERRIGO PHARMA

  • Officer
803 2016-02-26 0

COUCKE MARC EXECUTIVE VP & GM

  • Officer
5,397,711 2016-02-26 0

GOTTFRIED RAN

  • Director
12,728 2015-11-19 0

GIBBONS DAVID T

  • Director
14,191 2015-11-04 0

SHAH JATIN SR VP & CHIEF SCIENTIFIC OFFIC

  • Officer
4,426 2015-08-21 0

YU LOUIS EXECUTIVE VP GLOBAL QUALITY

  • Officer
10,898 2015-08-21 0

STEWART MICHAEL ROBERT SR. VP GLOBAL HUMAN RESOURCES

  • Officer
4,292 2015-08-21 0

JAMISON SCOTT F

  • EXECUTIVE VICE PRESIDENT PBM
5,196 2015-08-21 0

ZILBERFARB BEN-ZION

  • Director
0 2013-12-18 0

LEBEL REFAEL EVP & GM PERRIGO ISRAEL

  • Officer
6,218 2011-12-01 0

ARKIN MOSHE

  • Director
4,984,397 2011-08-31 0

MANNING PAUL B EVP & GENERAL MANAGER, PBM

  • Officer
0 2010-06-09 0

TOMSHACK JAMES SENIOR VP OF CHC SALES

  • Officer
8,914 2009-08-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DILLARD JAMES E III - Officer EVP, CHIEF SCIENTIFIC OFFICER

2021-02-08 07:27:07 -0500 2021-02-05 F 1,396 $43.09 d 7,517 direct

DILLARD JAMES E III - Officer EVP, CHIEF SCIENTIFIC OFFICER

2021-02-08 07:27:07 -0500 2021-02-05 M 4,297 a 8,913 direct

DILLARD JAMES E III - Officer EVP, CHIEF SCIENTIFIC OFFICER

2021-02-08 07:27:07 -0500 2021-02-05 M 4,297 d 4,297 direct

SOROTA RICHARD S - Officer EVP & PRESIDENT CSCA

2021-01-07 12:31:59 -0500 2021-01-06 P 7,513 $43.48 a 7,513 direct yes -2.9565 -2.9348 -8.1809 0.5389 5 -8.2245 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PERRIGO CO PLC PRGO 2021-03-01 19:15:03 UTC -0.1887 0.2587 1400000
PERRIGO CO PLC PRGO 2021-03-01 18:45:03 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 18:15:03 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 17:45:03 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 17:15:03 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 16:45:03 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 16:15:02 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 15:45:03 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 15:15:02 UTC -0.2228 0.2928 1400000
PERRIGO CO PLC PRGO 2021-03-01 14:45:03 UTC -0.18 0.25 1400000
PERRIGO CO PLC PRGO 2021-03-01 14:15:03 UTC -0.18 0.25 1400000
PERRIGO CO PLC PRGO 2021-03-01 13:45:03 UTC -0.18 0.25 1400000
PERRIGO CO PLC PRGO 2021-03-01 13:15:03 UTC -0.18 0.25 1400000
PERRIGO CO PLC PRGO 2021-03-01 12:45:03 UTC -0.18 0.25 1300000
PERRIGO CO PLC PRGO 2021-02-26 22:15:02 UTC -0.18 0.25 6200000
PERRIGO CO PLC PRGO 2021-02-26 21:45:03 UTC -0.18 0.25 6200000
PERRIGO CO PLC PRGO 2021-02-26 21:15:02 UTC -0.18 0.25 6200000
PERRIGO CO PLC PRGO 2021-02-26 20:45:03 UTC -0.1879 0.2579 6200000
PERRIGO CO PLC PRGO 2021-02-26 20:15:03 UTC -0.1879 0.2579 6200000
PERRIGO CO PLC PRGO 2021-02-26 19:45:03 UTC -0.1879 0.2579 6200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Principal Funds, Inc- Global Multi-Strategy Fund PRGO 16827.0 shares, $-811397.94 2020-11-30 N-PORT
FundVantage Trust- Gotham Hedged Core Fund PRGO -613.0 shares, $-27413.36 2020-12-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund PRGO -34.0 shares, $-1520.48 2020-12-31 N-PORT
FundVantage Trust- Gotham Absolute 500 Core Fund PRGO -34.0 shares, $-1635.06 2020-03-31 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund PRGO -434.0 shares, $-19408.48 2020-12-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund PRGO -277.0 shares, $-13320.93 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund PRGO -199.0 shares, $-11122.11 2019-09-30 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund PRGO -2137.0 shares, $-95566.64 2020-12-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF PRGO -6913.0 shares, $-309149.36 2020-12-31 N-PORT

Elevate your investments